The Campbell Family Institute for Cancer Research

Amount
$100,000.00
Date
October 2017

Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets

Children's Cancer Institute (AU)

Amount
$185,706.00
Date
October 2017

Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1

Stanford University

Amount
$200,000.00
Date
October 2017

Targeting neuronal activity regulated DIPG infiltration

Cincinnati Children's Hospital Medical Center

Cincinnati Children's Hospital Medical Center

Amount
$2,759,496.00
Date
October 2017

CONNECT Collaborative

Anchutz Medical Campus

Amount
$50,000.00
Date
October 2017

Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.

Dana-Farber Cancer Institute

Amount
$100,000.00
Date
October 2017

Defining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-sequencing analyses

Memorial Sloan Kettering Cancer Center

Amount
$100,000.00
Date
October 2017

Targeting EZH2 as a therapeutic strategy in DIPG

The Hospital of Sick Children

Amount
$162,828.00
Date
October 2017

Targeting DIPG through pharmacological activation of mitochondrial biogenesis: an in vitro and in vivo preclinical study